A British court rejected Kellogg's arguments in its legal action against the UK government over new regulations preventing it from prominently displaying some of its breakfast cereals in supermarkets due to their sugar content.
Kellogg argued that the UK government's way of measuring the nutritional value of cereal without milk or yogurt is “wrong”.
The new regulations, which come into effect in October, are designed to help tackle childhood obesity and will restrict the promotion of food and drink products that are high in fat, salt, or sugar.
Kellogg noted that it supported the government’s work to tackle obesity, demonstrated by its past efforts to reduce sugar and salt in its cereals.
A Kellogg spokesperson said that while they respect the court's decision and do not intend to appeal, they still believe that cereals should be measured with milk as it is the way most people eat them.
They also raised their concern that the government introduced these regulations without proper parliamentary scrutiny.


Why the future of marijuana legalization remains hazy despite high public support
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
US and EU Strengthen Critical Minerals Partnership to Reduce China Dependence
Asian Markets Mixed as Oil Prices Rise Amid Middle East Tensions and Ceasefire Uncertainty
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
Oil Prices Surge Amid Escalating U.S.-Iran Conflict and Strait of Hormuz Tensions
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Justice Jackson Slams Supreme Court's Growing Use of Shadow Docket
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Trump Administration Seeks Emergency Order to Resume White House Ballroom Construction
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



